![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Novel agent therapies are improving R/R PTCL outcomes (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Novel Agents and Chemotherapy Regimens in PTCL (OncLive) View |
![]() |
Novel Treatment Strategies for Peripheral T-cell Lymphomas (OncLive) View |
![]() |
New Targets in peripheral T cell lymphomas (HMP Education) View |
![]() |
Phase 3 Study Peripheral T-Cell Lymphoma: Alisertib Versus Investigator’s Choice (MPNUniversity .tv) View |
![]() |
The Current Unmet Needs in PTCL Treatment and Prospects (OncLive) View |
![]() |
Azacitidine and CHOP in PTCL (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
PTCL arising as a PTLD: the efficacy of pralatrexate (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
The TOTAL trial: brentuximab vedotin + gemcitabine in R/R peripheral T-cell lymphoma (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Novel Therapies in Pediatric AML: Blood Drop Series at ASH-a-Palooza 2019 (American Society of Hematology) View |